Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Henry Ford Hospital, Detroit, Michigan, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
UF Health, Gainesville, Florida, United States
First Affiliated Hosipital of Xi'an Jiaotong Univercity, Xi'an, Shaanxi, China
Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States
Foisor Orthopedic Clinical Hospital, Bucharest, Romania
Fujian Provincial Hospital, Fuzhou, Fujian, China
Meander Medical Center, Amersfoort, Netherlands
VU Medical Center, Amsterdam, Netherlands
Academic Medical Center, Amsterdam, Netherlands
Kingston General Hospital, Kingston, Ontario, Canada
University of California Davis Med Center- Trauma and Acute Care Surgery, Sacramento, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.